Bristol-Myers Squibb Company (BMY) vs Danaher Corporation (DHR)
BMY leads on 14 of 16 compared metrics.
A side-by-side comparison of Bristol-Myers Squibb Company and Danaher Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 13, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BMY
Bristol-Myers Squibb Company
$57.13Healthcare
DHR
Danaher Corporation
$180.10Healthcare
Total return — BMY vs DHR
growth of $100 · last 30yBMY +171.1%DHR +5181.5%DHR compounded faster
Log scale — wide-divergence pair
BMY DHR
BMY vs DHR: by the numbers
- •DHR is the larger company ($127.47B vs $116.66B market cap).
- •BMY trades at the lower earnings multiple (16.05 vs 34.84 P/E).
- •BMY converts more revenue to profit (15.01% vs 14.89% net margin).
- •BMY grew revenue faster over the past five years (2.52% vs 2.05% CAGR).
- •BMY pays the higher dividend yield (4.38% vs 0.76%).
Which is better, BMY or DHR?
Metric tally: BMY 14 · DHR 2It depends on what you're optimizing for:
ValueBMY(lower P/E)
GrowthBMY(faster 5Y revenue CAGR)
IncomeBMY(higher dividend yield)
QualityBMY(higher ROIC)
Valuation
| Metric | BMY | DHR |
|---|---|---|
| P/E ratio | 16.05● | 34.84 |
| Forward P/E | 9.31● | 19.73 |
| P/S ratio | 2.41● | 5.17 |
| P/B ratio | 5.82 | 2.42● |
| PEG ratio | 1.71● | 87.09 |
| EV / EBITDA | 11.03● | 21.20 |
| FCF yield | 10.20%● | 4.13% |
Profitability
| Metric | BMY | DHR |
|---|---|---|
| Gross margin | 68.75%● | 60.68% |
| Operating margin | 25.67%● | 20.95% |
| Net margin | 15.01% | 14.89% |
| ROE | 36.25%● | 6.97% |
| ROIC | 13.90%● | 5.72% |
Dividends
| Metric | BMY | DHR |
|---|---|---|
| Dividend yield | 4.38%● | 0.76% |
| Payout ratio | 72.25% | 26.82% |
Growth (annualized)
| Metric | BMY | DHR |
|---|---|---|
| Revenue CAGR (5Y) | 2.52%● | 2.05% |
| EPS CAGR (5Y) | 9.38%● | 0.40% |
| FCF CAGR (5Y) | -2.50% | -0.45%● |
| Total return CAGR (5Y) | 0.74%● | -3.38% |
Frequently asked
- Which is better, BMY or DHR?
- It depends on your goal. value: BMY (lower P/E); growth: BMY (faster 5Y revenue CAGR); income: BMY (higher dividend yield); quality: BMY (higher ROIC). Across all compared metrics, BMY leads 14 to 2.
- Is BMY or DHR cheaper?
- On trailing earnings, BMY is cheaper: BMY trades at a 16.05 P/E and DHR at 34.84.
- Which has grown faster, BMY or DHR?
- Over the past five years, BMY grew revenue faster — BMY at a 2.52% CAGR versus DHR at 2.05%.
- Does BMY or DHR pay a bigger dividend?
- BMY yields 4.38% and DHR yields 0.76% based on trailing dividends and the latest price.
- Is BMY or DHR more profitable?
- BMY runs the higher net margin — BMY at 15.01% versus DHR at 14.89%.
- Which has been the better investment, BMY or DHR?
- Over the past 10-year, DHR delivered the higher annualized total return — BMY at 1.08% versus DHR at 10.98%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bristol-Myers Squibb P/E ratioDanaher P/E ratioBristol-Myers Squibb dividend yieldDanaher dividend yieldBristol-Myers Squibb ROEDanaher ROEBristol-Myers Squibb operating marginDanaher operating marginBristol-Myers Squibb revenue growthDanaher revenue growthBristol-Myers Squibb free cash flowDanaher free cash flow
Bristol-Myers Squibb & Danaher appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 13, 2026.